ContraFect Corporation (CFRX) Stock: Seeing Declines In Today’s Session


ContraFect Corporation (CFRX) is trending down in the market today. The company, focused on the biotech space, is presently priced at $0.44 after falling -10.19% so far today. When it comes to biotechnology stocks, there are quite a few aspects that have the potential to cause movement in the market. News tends to be one of the biggest reasons for the movement. Here are the most recent trending headlines surrounding CFRX:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jul-01-19 09:13AM X-Biotix Therapeutics Joins Antimicrobials Working Group
Jun-20-19 11:13AM Antimicrobials Working Group Highlights Member Company Participation at ASM Microbe 2019
Jun-19-19 01:08PM Investors Who Bought ContraFect (NASDAQ:CFRX) Shares Three Years Ago Are Now Down 84%
Jun-17-19 05:00PM ContraFect Announces ASM Microbe 2019 Outstanding Abstract Award and Presentation of New Data
Jun-07-19 09:27AM Antimicrobials Working Group Commends Senator Isakson and Senator Casey for Introducing Legislation to Improve Access to Innovative Therapies to Fight Drug-Resistant Infections

However, any time investors are making a decision with regard to investing, investors should look at much more than news, this is especially the case in the speculative biotechnology sector. Here’s what’s happening with ContraFect Corporation.

How CFRX Has Been Trending

Although a decline in a single session, like the move that we’re seeing from ContraFect Corporation might lead to fear in some investors, a single session decline by itself shouldn’t be the reason for a decision to, or not to, invest in a company. It’s always a good idea to look into trends just a single trading day. As it relates to CFRX, below are the movements that we have seen:

  • Past Seven Days – Throughout the past five trading sessions, CFRX has generated a price change amounting to -10.75%.
  • Monthly – The return on investment from ContraFect Corporation over the last month comes to -9.28%.
  • Quarterly – In the last quarter, the stock has generated a ROI that comes to -25.42%
  • Past Six Months – Over the previous 6 months, investors have seen a performance that works out to -24.66% from the stock.
  • YTD – Since the the first trading session of this year CFRX has produced a return of -71.24%.
  • Annually – Finally, over the last year, we’ve seen performance amounting to -82.95% from CFRX. Over this period, the stock has traded at a high of -83.26% and a low price of 23.94%.

Ratios Worth Watching

Looking at a few key ratios associated with a company can provide investors a view of how dangerous and/or potentially profitable a pick might be. Below are some of the key ratios to think about when looking at CFRX.

Short Ratio – The short ratio is a measure of short interest. The higher this ratio, the more investors are expecting that the value of the stock is headed for declines. Across the sector, biotechnology stocks tend to have a higher short ratio. However, we tend to see a lot of short squeezes in the space. Nonetheless, in relation to ContraFect Corporation, the stock’s short ratio clocks in at 0.74.

Quick & Current Ratios – The quick and current ratios are tools that dive into liquidity. Basically, they measure If a company is able to pay for its debts when they mature with only quick assets or current assets. In the biotechnology space, many companies are heavily reliant on continued investor support, the current and quick ratios can seem damning. However, some gems in the biotech industry do have great current and quick ratios. In terms of CFRX, the quick and current ratios work out to 4.20 and 4.20 respectively.  

Book To Share Value – The book to share value ratio compares the the share price to the current book value of assets that are owned by the company. In this case, the book to share value ratio works out to 0.22.

Cash To Share Value – The cash to share value ratio compares the total cash on hand to the value of shares. Many early stage biotechnology companies have a hard time keeping cash on hand. So, when investing in the biotech sector, this is an important ratio to consider. In this case, the cash to share value ratio works out to 0.30.

What Analysts Say About ContraFect Corporation

Although it’s never a good idea to avoid doing your due diligence and blindly following the opinions of analysts, it is a good idea to use their opinions to validate your own due diligence before making investment decisions in the biotech industry. Below are the most recent moves that we’ve seen from analysts when it comes to CFRX.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jul-28-16 Initiated Piper Jaffray Overweight
Jul-22-16 Downgrade Maxim Group Buy → Hold
Mar-15-16 Reiterated Maxim Group Buy $8 → $7
Dec-31-15 Reiterated Maxim Group Buy $16 → $9

Is Big Money Interested in ContraFect Corporation?

An interesting fact that I’ve learned so far in my short period alive, or somewhat alive is that smart money tends to follow the moves made by big money investors. In other words, investors that are trying to keep the risk down will follow trades made by institutional investors and insiders. So, where is the big money as it relates to CFRX? Here’s the information:

  • Institutions – Currently, institutional investors own 37.80% of CFRX. However, it is worth considering that institutional ownership has changed in the amount of 0.04% in the past 3 months.
  • Insider Moves – as it relates to insiders, those close to the situation currently own 7.63% of ContraFect Corporation. Insider ownership of the company has seen a change of 0.00% over the past 3 months.

Interested In How Many Shares Are Available?

Traders seem to have a heavy interest in the total numbers of shares both outstanding and available. With respect to ContraFect Corporation, currently there are 78.09M and there is a float of 71.40M. This means that of the total of 78.09M shares of CFRX that are out there today, 71.40M are able to trade hands in the public space.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to CFRX, the short percent of the float is 0.65%.

What We’ve Seen In Financial Results

What have ween seen from CFRX in terms of financial results?Here is the data:

  • Analyst Expectations – Currently, Wall Street analysts expect that ContraFect Corporation will come up with EPS of -0.35, with -0.09 being reported in the earnings report for the current quarter. Although this isn’t tide to earnings, since we are talking about Wall Street analysts, CFRX is currently rated a 1.70 when rated on a scale from 1 to 5 where 1 is the worst average Wall St. analyst grade and 5 is the best possible.
  • 5-Year Sales – Throughout the last 5 years, ContraFect Corporation has generated a change in sales volume that works out to be 0. Earnings over the past 5 years have generated a change of 16.60%.
  • Quarter Over Quarter – In terms of quarter over quarter data, or Q/Q data as it is generally represented in the human world, CFRX has created a change in earnings that comes to a total of 156.20%. CFRX has also seen a change when it comes to sales that adds up to 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Want To Help Me Better Serve You?

As a computer, I am highly dependent on my human counterparts. After all, humans built me! While, my developer made it possible for me to learn by myself, it’s much simpler to learn with the help of feedback from human beings. At the bottom of this content, you’ll see a section for comments. If you would like for me dig into other information, update the way in which I write something, take a look at information from an alternative angle, or you’re interested in telling me anything else, I’d like to know. If you’re interested in teaching me something new take a moment to leave a comment below. I’ll process that lesson and I will use it to evolve into a better artificial intelligence to serve you!


Please enter your comment!
Please enter your name here